DUOL
Duolingo, Inc.
DUOL trails on the overall score without a compensating advantage in the available component scores.
MU
Micron Technology, Inc.
MU has the edge over DUOL overall, supported by stronger modeled upside and lower modeled downside.
DUOL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
DUOL's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
DUOL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $46.37 | -71% |
| Current | 51x | $157 | — |
| Forward | 51x | $157 | — |
| Fair | 151x | $464 | +195% |
| Expensive | 207x | $637 | +305% |
Historical ranges are pointers, not guarantees.
DUOL's PE is in its fair range at 51.1x. On analysts' estimates for next year's earnings, today's price would be 51.4x.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over DUOL in the historical PE scenario, which offers more potential upside but is not a forecast.
DUOL Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for DUOL, but weaker profitability. However, they disagree widely on these estimates.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over DUOL on the outlook, with more favorable valuation and profitability expectations.
DUOL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.07 | -0.5% |
| Q3 2026 | $3.08 | -61% |
| Q2 2026 | $8.49 | +249% |
| Q1 2026 | $8.74 | +331% |
| Q4 2025 | $8.57 | +356% |
| Q3 2025 | $7.89 | +329% |
| Q2 2025 | $2.43 | +72% |
| Q1 2025 | $2.03 | +107% |
| Q4 2024 | $1.88 | +437% |
DUOL earned $3.08 per share over the past year, down 61% from the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over DUOL on earnings, with more consistent year-over-year improvement.
DUOL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $309M | +14% |
| Q2 2026 | $298.5M | +18% |
| Q1 2026 | $292M | +27% |
| Q4 2025 | $282.9M | +35% |
| Q3 2025 | $271.7M | +41% |
| Q2 2025 | $252.3M | +41% |
| Q1 2025 | $230.7M | +38% |
| Q4 2024 | $209.6M | +39% |
DUOL's revenue has grown year over year every quarter since late 2020: $309M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.8% | -5.1 points |
| Q2 2026 | 11% | -1.9 points |
| Q1 2026 | 15% | +5 points |
| Q4 2025 | 15% | +8.7 points |
| Q3 2025 | 13% | +5.9 points |
| Q2 2025 | 13% | +2.7 points |
| Q1 2025 | 10% | +0.4 points |
| Q4 2024 | 6.6% | +3.4 points |
DUOL's operating margin was 7.8% last quarter, down 5.1 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over DUOL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over DUOL on profitability, with a higher operating margin.
DUOL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $78.5M | -1.1% |
| Q2 2026 | $81.4M | -9.1% |
| Q1 2026 | $150.6M | +44% |
| Q4 2025 | $96.6M | +19% |
| Q3 2025 | $79.4M | +50% |
| Q2 2025 | $89.5M | +57% |
| Q1 2025 | $104.3M | +27% |
| Q4 2024 | $81.4M | +69% |
DUOL generated $407M in free cash flow over the past year, up 15% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over DUOL on cash flow, with more consistent year-over-year improvement.
DUOL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -7.6x | Net Cash |
| Q2 2026 | -6.8x | Net Cash |
| Q1 2026 | -6.6x | Net Cash |
| Q4 2025 | -6.9x | Net Cash |
| Q3 2025 | -8.4x | Net Cash |
| Q2 2025 | -10.0x | Net Cash |
| Q1 2025 | -10.8x | Net Cash |
| Q4 2024 | -10.7x | Net Cash |
DUOL has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
DUOL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.9 | Neutral |
| Stochastic | 58.5 | Neutral |
DUOL's weekly RSI is 58 (neutral) and its Stochastic is 59 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
DUOL PE vs Technology Sector
| Metric | DUOL | Sector median | Relative |
|---|---|---|---|
| PE | 51x | 28x | 83% above |
| PE % | 37 | 44 | 7 pts below |
DUOL is trading at 51x earnings, a 83% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over DUOL on valuation relative to its sector.
DUOL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $146.5 | 7.5% above |
| 20 week MA | $140.5 | 12% above |
| 50 week MA | $132.5 | 19% above |
| 100 week MA | $241.7 | 35% below |
| 200 week MA | $215.7 | 27% below |
DUOL has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 27% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
DUOL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $140.3 | $109.0 | -22% |
| 2022 | $109.0 | $70.7 | -35% |
| 2023 | $70.7 | $226.9 | +221% |
| 2024 | $226.9 | $333.3 | +47% |
| 2025 | $333.3 | $181.7 | -46% |
| 2026 YTD | $181.7 | $157.4 | -13% |
DUOL's yearly returns have swung widely, from +221% in 2023 to −46% in 2025. It's down 13% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over DUOL on returns for 2026, with the stronger performance.